Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research
Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research
IN THE FUTURE, ALZHEIMER’S MAY BE PREDICTED DURING EYE EXAMS
RPB-funded researchers at Washington University School of Medicine in St. Louis (WUSTL) have found a correlation in 30 older patients between retina thinning and elevated levels of tau and amyloid proteins that are the hallmark of Alzheimer’s disease.
Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2018 Recipient of RPB David F. Weeks Award for Outstanding AMD Research
RPB and AUPO announce 2018 recipient of David F. Weeks Award for outstanding AMD research.
Groundbreaking Gene Therapy for Retinal Disease
The first patient receives an FDA-approved gene therapy for inherited retinal disease at Mass. Eye and Ear.
RPB and AAO Award Grants for Big Data Research to Advance Patient Care
Award recipients to use IRIS Registry database to conduct population-based studies.
Research to Prevent Blindness Expands Grants Program
Many of the organization’s individual grants will now be open to researchers at any U.S. academic medical center.
Study Tests Stem Cell-based Therapy for Advanced Dry AMD
RPB-supported researchers at the University of Southern California Roski Eye Institute conducted the human trial.
Study Links Aging Immune Cells and AMD
RPB-supported researchers at Washington University School of Medicine in St. Louis published the new findings.
The National Eye Institute Turns 50
RPB celebrates five decades of sight-saving discoveries at NEI.
Vision Funders Collaborate for Impact
RPB hosted its fifth annual convening of organizations that fund vision research in Washington DC.
RPB and AAO Announce New Grant Opportunities to Support Vision Research
Partnership to utilize IRIS Registry database to advance patient care.
Reversing Retinal Degenerative Diseases: We’re One Step Closer
RPB-supported researchers made a critical discovery about the gene mutation that causes many retinal degenerative diseases, opening the door for a new line of research into potential treatments.
Subscribe
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
| General Info | Research Scientists & Grantees | Eye Care Specialists | Donors & Partners |
Research to Prevent Blindness
360 Lexington Avenue, 22nd Floor
New York, NY 10017
(212) 752-4333
Copyright © 2018 Research to Prevent Blindness. All Rights Reserved.
